Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
+1.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | +62.3% |
| 2024 | 0.01 | +23.0% |
| 2023 | 0.01 | -47.0% |
| 2022 | 0.02 | - |
| 2021 | 0.00 | +100.0% |
| 2020 | -0.02 | +96.4% |
| 2019 | -0.59 | - |